OVERVIEW

2026 Tutorial on Neoplastic Hematopathology: Focus on New Classifications is organized by The University of Chicago - Center for Continuing Medical Education and will be held from Jan 18 - 22, 2026 at Hyatt Regency Phoenix, Phoenix, Arizona, United States of America.

Description:
Continuing in the tradition of 40+ years of tutorials, the 2026 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Hyatt Regency Phoenix Hotel from January 18-22, 2026. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.

Learning Objectives:
At the conclusion of this activity, participants will be able to:

  • Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology
  • State how to utilize recent advances in the classification of hematopoietic tumors;
  • Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
  • Describe how to implement the most recent classification of hematologic neoplasms;
  • Recall new discoveries that might impact future classifications of hematologic neoplasms;
  • Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.

KEY DATES

Event Start Date
18 Jan, 2026
Event Start Date
Event End Date
22 Jan, 2026
Event End Date
Credits

Physician Credit:
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology Lifelong Learning (CME) Credit:
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.

Other Health Professional Credit:
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

  • 33.75 AMA PRA Category 1 Credits™
  • 33.75 CME
  • TARGET AUDIENCE

    PhysicianOncologistsHealthcare ProfessionalsHematologistPathologists

    SPECIALITIES

    HematopathologyOncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationHyatt Regency Phoenix
    122 N 2nd St

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235